Bing Jiang

About Bing Jiang

Bing Jiang, With an exceptional h-index of 11 and a recent h-index of 11 (since 2020), a distinguished researcher at Zhengzhou University, specializes in the field of Nanobiotechnology, Tumor targeted theranostics, Nanozyme, Ferritin.

His recent articles reflect a diverse array of research interests and contributions to the field:

Self‐Assembly of Heterogeneous Ferritin Nanocages for Tumor Uptake and Penetration

Nanozymes: a new approach for leukemia therapy

纳米酶

Cancer cell membrane fused liposomal platinum (iv) prodrugs overcome cisplatin resistance in esophageal squamous cell carcinoma chemotherapy

Tackling Esophageal Squamous Cell Carcinoma with ITFn‐Pt (IV): A Novel Fusion of PD‐L1 Blockade, Chemotherapy, and T‐cell Activation

CLMP is a tumor suppressor that determines all-trans retinoic acid response in colorectal cancer

Engineering multifunctional thylakoid as an oxygen self-supplying photosensitizer for esophageal squamous cell carcinoma-targeted photodynamic therapy

Advances in the Theranostics of Oesophageal Squamous Carcinoma

Bing Jiang Information

University

Position

___

Citations(all)

914

Citations(since 2020)

908

Cited By

129

hIndex(all)

11

hIndex(since 2020)

11

i10Index(all)

13

i10Index(since 2020)

13

Email

University Profile Page

Google Scholar

Bing Jiang Skills & Research Interests

Nanobiotechnology

Tumor targeted theranostics

Nanozyme

Ferritin

Top articles of Bing Jiang

Self‐Assembly of Heterogeneous Ferritin Nanocages for Tumor Uptake and Penetration

Advanced Science

2024/2/17

Nanozymes: a new approach for leukemia therapy

2024

纳米酶

化学进展

2023/1/24

Cancer cell membrane fused liposomal platinum (iv) prodrugs overcome cisplatin resistance in esophageal squamous cell carcinoma chemotherapy

Journal of Materials Chemistry B

2023

Wei Jiang
Wei Jiang

H-Index: 4

Bing Jiang
Bing Jiang

H-Index: 5

Tackling Esophageal Squamous Cell Carcinoma with ITFn‐Pt (IV): A Novel Fusion of PD‐L1 Blockade, Chemotherapy, and T‐cell Activation

Advanced Healthcare Materials

2023/12/24

Qi Xin
Qi Xin

H-Index: 5

Bing Jiang
Bing Jiang

H-Index: 5

CLMP is a tumor suppressor that determines all-trans retinoic acid response in colorectal cancer

Developmental Cell

2023/12/4

Engineering multifunctional thylakoid as an oxygen self-supplying photosensitizer for esophageal squamous cell carcinoma-targeted photodynamic therapy

CCS Chemistry

2023/11/1

Advances in the Theranostics of Oesophageal Squamous Carcinoma

2023/7

Mitochondria-targeted nanozymes eliminate oxidative damage in retinal neovascularization disease

Journal of Controlled Release

2022/10/1

Edge‐Site Engineering of Defective Fe–N4 Nanozymes with Boosted Catalase‐Like Performance for Retinal Vasculopathies

Advanced Materials

2022/9

Ferritin nanocages for early theranostics of tumors via inflammation-enhanced active targeting

Science China Life Sciences

2022/2/1

Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy

Theranostics

2022

Bioengineered dual‐targeting protein nanocage for stereoscopical loading of synergistic hydrophilic/hydrophobic drugs to enhance anticancer efficacy

Advanced Functional Materials

2021/7

Nanocage‐Based Capture‐Detection System for the Clinical Diagnosis of Autoimmune Disease

Small

2021/6

Yanan Zhang
Yanan Zhang

H-Index: 1

Bing Jiang
Bing Jiang

H-Index: 5

High-performance self-cascade pyrite nanozymes for apoptosis–ferroptosis synergistic tumor therapy

ACS nano

2021/3/11

纳米酶标准术语

中国科技术语

2020

A natural drug entry channel in the ferritin nanocage

Nano Today

2020/12/1

Bing Jiang
Bing Jiang

H-Index: 5

Long Ma
Long Ma

H-Index: 4

Ferritins as natural and artificial nanozymes for theranostics

2020

Bing Jiang
Bing Jiang

H-Index: 5

Platinum-carbon-integrated nanozymes for enhanced tumor photodynamic and photothermal therapy

Nanoscale

2020

See List of Professors in Bing Jiang University(Zhengzhou University)